Antonella Mercurio

No ORCID on file · 6 papers in corpus
observational 2024
Scientific reports ·doi:10.1038/s41598-024-73151-y

To evaluate if a preoperative medical treatment with the GnRH-antagonist relugolix in combination therapy in a series of patients with abnormal uterine bleeding associated with uterine myomas may correct the anemia before scheduled surgery …

observational 2023
Archives of gynecology and obstetrics ·doi:10.1007/s00404-023-07271-7

PURPOSE: To evaluate the efficacy and long-term safety (up to 108 months) of treatment with Dienogest in patients with endometriosis. METHODS: Patients with chronic pelvic pain endometriosis-related were enrolled in this observational stud…

observational 2023
Archives of gynecology and obstetrics ·doi:10.1007/s00404-023-06942-9

PURPOSE: The aims of this observational study were: to assess the relationship between psychological variables, pain, Duration Untreated Endometriosis (DUE) in a sample of women with Endometriosis; and to assess the effect of dienogest 2 mg…

2023
·doi:10.21203/rs.3.rs-2148443/v1

Abstract Purpose: The aims of this observational study were: to assess the relationship between psychological variables, pain, Duration Untreated Endometriosis (DUE) in a sample of women with Endometriosis; and to assess the effect of Dien…

observational 2017
Archives of gynecology and obstetrics ·doi:10.1007/s00404-017-4442-5

PURPOSE: Dienogest has recently been marketed as a medical treatment for endometriosis. Given the recent introduction on the market of Dienogest, little data are available regarding its effectiveness in routine clinical practice. METHODS: …

review 2017
·doi:10.5301/jeppd.5000292

Endometriosis causes a decrease in fertility in affected patients. The different forms of the disease, peritoneal, ovarian, deep infiltrating and adenomyosis, are often present in varying degrees in the same patient, either together or indi…